Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study.

Wang J, Carvajal-Carmona LG, Chu JH, Zauber AG; APC Trial Collaborators, Kubo M, Matsuda K, Dunlop M, Houlston RS, Sieber O, Lipton L, Gibbs P, Martin NG, Montgomery GW, Young J, Baird PN, Ratain MJ, Nakamura Y, Weiss ST, Tomlinson I, Bertagnolli MM.

Clin Cancer Res. 2013 Dec 1;19(23):6430-7. doi: 10.1158/1078-0432.CCR-13-0550. Epub 2013 Oct 1.

PMID:
24084763
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: a randomized, double-blind, placebo-controlled study.

Berry SM, Barish CF, Bhandari R, Clark G, Collins GV, Howell J, Pappas JE, Riff DS, Safdi M, Yellowlees A.

BMC Gastroenterol. 2013 Jul 1;13:106. doi: 10.1186/1471-230X-13-106.

PMID:
23815124
[PubMed - in process]
Free PMC Article
3.

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group.

N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572.

PMID:
23075178
[PubMed - indexed for MEDLINE]
Free Article
4.

Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.

Sandborn WJ, Hanauer S, Lichtenstein GR, Safdi M, Edeline M, Scott Harris M.

Aliment Pharmacol Ther. 2011 Oct;34(7):747-56. doi: 10.1111/j.1365-2036.2011.04800.x. Epub 2011 Aug 16.

PMID:
21848857
[PubMed - indexed for MEDLINE]
5.

Strategies in maintenance for patients receiving long-term therapy (SIMPLE): a study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis.

Kane S, Katz S, Jamal MM, Safdi M, Dolin B, Solomon D, Palmen M, Barrett K.

Inflamm Bowel Dis. 2012 Jun;18(6):1026-33. doi: 10.1002/ibd.21841. Epub 2011 Aug 11.

PMID:
21837775
[PubMed - indexed for MEDLINE]
6.

5-ASA Dose-Response: Maximizing Efficacy and Adherence.

Katz S, Lichtenstein GR, Safdi MA.

Gastroenterol Hepatol (N Y). 2010 Feb;6(2 Suppl 3):1-16.

PMID:
20567558
[PubMed]
Free PMC Article
7.

Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.

Bertagnolli MM, Hsu M, Hawk ET, Eagle CJ, Zauber AG; Adenoma Prevention with Celecoxib (APC) Study Investigators.

Cancer Prev Res (Phila). 2010 May;3(5):588-96. doi: 10.1158/1940-6207.CAPR-09-0271. Epub 2010 Apr 19.

PMID:
20403998
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.

Sandborn WJ, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S.

Gastroenterology. 2010 Apr;138(4):1286-96, 1296.e1-3. doi: 10.1053/j.gastro.2009.12.054. Epub 2010 Jan 11.

PMID:
20064514
[PubMed - indexed for MEDLINE]
9.

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.

Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Breazna A, Kim K, Tang J, Rosenstein RB, Umar A, Bagheri D, Collins NT, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Hawk ET; Adenoma Prevention with Celecoxib Study Investigators.

Cancer Prev Res (Phila). 2009 Apr;2(4):310-21. doi: 10.1158/1940-6207.CAPR-08-0206. Epub 2009 Mar 31.

PMID:
19336730
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.

Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR, Katz S, Johanns J, Blank M, Rutgeerts P; Ustekinumab Crohn's Disease Study Group.

Gastroenterology. 2008 Oct;135(4):1130-41. doi: 10.1053/j.gastro.2008.07.014. Epub 2008 Jul 17.

PMID:
18706417
[PubMed - indexed for MEDLINE]
11.

A new look at a mainstay ulcerative colitis therapy.

Sninsky CA, Safdi M, Katz S.

Gastroenterol Hepatol (N Y). 2008 Feb;4(2 Suppl 4):1-12. No abstract available.

PMID:
21904481
[PubMed]
Free PMC Article
12.

The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis.

Safdi M, Bekal PK, Martin S, Saeed ZA, Burton F, Toskes PP.

Pancreas. 2006 Aug;33(2):156-62. Erratum in: Pancreas. 2007 Jan;34(1):174.

PMID:
16868481
[PubMed - indexed for MEDLINE]
13.

Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.

Sands BE, Sandborn WJ, Wolf DC, Katz S, Safdi M, Schwartz DA, Hanauer SB.

J Clin Gastroenterol. 2006 Jul;40(6):482-9.

PMID:
16825929
[PubMed - indexed for MEDLINE]
14.

Quality indicators for endoscopic ultrasonography.

Jacobson BC, Chak A, Hoffman B, Baron TH, Cohen J, Deal SE, Mergener K, Petersen BT, Petrini JL, Safdi MA, Faigel DO, Pike IM; ASGE/ACG Taskforce on Quality in Endoscopy.

Am J Gastroenterol. 2006 Apr;101(4):898-901. No abstract available.

PMID:
16635234
[PubMed - indexed for MEDLINE]
15.

Quality indicators for endoscopic retrograde cholangiopancreatography.

Baron TH, Petersen BT, Mergener K, Chak A, Cohen J, Deal SE, Hoffinan B, Jacobson BC, Petrini JL, Safdi MA, Faigel DO, Pike IM; ASGE/ACG Taskforce on Quality in Endoscopy.

Am J Gastroenterol. 2006 Apr;101(4):892-7. No abstract available.

PMID:
16635233
[PubMed - indexed for MEDLINE]
16.

Quality indicators for esophagogastroduodenoscopy.

Cohen J, Safdi MA, Deal SE, Baron TH, Chak A, Hoffman B, Jacobson BC, Mergener K, Petersen BT, Petrini JL, Rex DK, Faigel DO, Pike IM; ASGE/ACG Taskforce on Quality in Endoscopy.

Am J Gastroenterol. 2006 Apr;101(4):886-91. No abstract available.

PMID:
16635232
[PubMed - indexed for MEDLINE]
17.

Quality indicators for colonoscopy.

Rex DK, Petrini JL, Baron TH, Chak A, Cohen J, Deal SE, Hoffman B, Jacobson BC, Mergener K, Petersen BT, Safdi MA, Faigel DO, Pike IM; ASGE/ACG Taskforce on Quality in Endoscopy.

Am J Gastroenterol. 2006 Apr;101(4):873-85. No abstract available.

PMID:
16635231
[PubMed - indexed for MEDLINE]
18.

Quality indicators for gastrointestinal endoscopic procedures: an introduction.

Faigel DO, Pike IM, Baron TH, Chak A, Cohen J, Deal SE, Hoffman B, Jacobson BC, Mergener K, Petersen BT, Petrini JL, Rex DK, Safdi MA; ASGE/ACG Taskforce on Quality in Endoscopy.

Am J Gastroenterol. 2006 Apr;101(4):866-72. No abstract available.

PMID:
16635230
[PubMed - indexed for MEDLINE]
19.

Quality indicators for endoscopic ultrasonography.

Jacobson BC, Chak A, Hoffman B, Baron TH, Cohen J, Deal SE, Mergener K, Petersen BT, Petrini JL, Safdi MA, Faigel DO, Pike IM.

Gastrointest Endosc. 2006 Apr;63(4 Suppl):S35-8. Review. No abstract available.

PMID:
16564910
[PubMed - indexed for MEDLINE]
20.

Quality indicators for endoscopic retrograde cholangiopancreatography.

Baron TH, Petersen BT, Mergener K, Chak A, Cohen J, Deal SE, Hoffman B, Jacobson BC, Petrini JL, Safdi MA, Faigel DO, Pike IM.

Gastrointest Endosc. 2006 Apr;63(4 Suppl):S29-34. Review. No abstract available.

PMID:
16564909
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk